Mavik and Clonidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mavik (trandolapril) and Clonidine (clonidine). Common drug interactions include hypotension among females and bradycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Mavik and Clonidine. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Mavik?

Mavik has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 3,145 Mavik users. Check the latest studies of Mavik.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.



On Jul, 10, 2026

30 people who take Mavik and Clonidine together, and have interactions are studied.

Mavik and Clonidine drug interactions.

What are the common drug interactions of Mavik and Clonidine, by gender? *:

female:

  1. Hypotension (abnormally low blood pressure)
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Thirst
  4. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  5. Acute left ventricular failure (heart attack)
  6. Acute respiratory failure
  7. Bladder pain
  8. Blood pressure decreased
  9. Chronic kidney disease
  10. Dizziness

male:

  1. Bradycardia (abnormally slow heart action)
  2. Fatigue (feeling of tiredness)
  3. Nervousness
  4. Pain
  5. Pain in limb
  6. Renal injury (kidney injury)
  7. Abdominal hernia
  8. Abdominal pain
  9. Abdominal tenderness
  10. Abnormal sleep-related event

What are the common drug interactions of Mavik and Clonidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Back pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Heart rate irregular
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Hypotension (abnormally low blood pressure)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Rash
  8. Vision blurred

50-59:

  1. Chronic kidney disease
  2. Haemorrhage intracranial (bleeding within the skull)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Nephropathy (damage to or disease of a kidney)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Renal failure (kidney dysfunction)
  8. Renal injury (kidney injury)
  9. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  10. Bradycardia (abnormally slow heart action)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Dizziness
  3. Heart rate decreased
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Injury
  7. Nervousness
  8. Pallor
  9. Renal failure (kidney dysfunction)
  10. Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

  1. Diabetes: 5 people, 16.67%
  2. Cardiac Disorder: 5 people, 16.67%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 13.33%
  4. Renal Disorder (kidney disease): 4 people, 13.33%
  5. Pain: 4 people, 13.33%
  6. Nuclear Magnetic Resonance Imaging Brain: 4 people, 13.33%
  7. Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 10.00%
  8. Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 3 people, 10.00%
  9. Partial Seizures (seizures which affect only a part of the brain at onset): 3 people, 10.00%
  10. Stress And Anxiety: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and Clonidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mavik and Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mavik:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mavik and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clonidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on trandolapril and clonidine (the active ingredients of Mavik and Clonidine, respectively), and Mavik and Clonidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: